Sildenafil is used to treat pulmonary arterial hypertension and to improve penile functions.
Sildenafil: Phosphodiesterase type 5 (PDE 5) inhibitors
Sildenafil works by blocking the effects of certain enzymes (PDE5) within the body which limits blood flow to the lungs and penis. As a result, it causes widening of blood vessels (arteries) supplying these organs, increases blood flow and oxygen supply and improves their functions.
Consult your doctor if you experience:
The name of the medication is Viagra, which is a type of drug called a PDE5 inhibitor. Sildenafil is used to treat conditions inside the body where the chemicals (chemicals) within your body fail or where your body does not work as well (especially in high-levelupendre ). It is also used for prevention of pulmonary arterial hypertension and for enlarged prostate.
I take Viagra:The most common side effects of Sildenafil are:
–Sildenafil may also make you feel, like, stroke-like ( refer to therants by the severity of their effects for more information).
Dapoxetine 30 mg Tablet is a medicine used to treat erectile dysfunction (ED) in men. It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. Dapoxetine is a serotonin reuptake inhibitor (SRI) which helps to increase the time it takes to ejaculate and improve control over ejaculation.
Dapoxetine 30 mg Tablet is available in different strengths, such as 30 mg, 60 mg, and 90 mg. It is usually taken in the morning. You can also take it with or without food. It can be taken with or without food.
Dapoxetine 30 mg Tablet works by delaying the reuptake of serotonin in the brain to increase the time it takes to ejaculate and improve control over ejaculation. The effect of Dapoxetine 30 mg Tablet can last up to 36 hours, and the effect can last for up to 6 hours. It is important to note that Dapoxetine 30 mg Tablet should only be taken under the guidance of a healthcare professional. It is essential to consult a doctor before using this medication.
Dapoxetine 30 mg Tablet is available in the form of tablets that you can take orally. The recommended dosage of Dapoxetine 30 mg Tablet is one tablet per day. It is recommended to take the medication 30 minutes before engaging in sexual activity and to complete the entire course of treatment. You should not take the medication more than once a day.
The dosage of Dapoxetine 30 mg Tablet is based on your medical condition, response to treatment, and age. The initial dosage will depend on your response to the medication and severity of the condition.
Follow all the instructions of your doctor. The dosage is taken 30 minutes before sexual activity. Do not exceed the maximum dose of 60 mg per day. It is recommended to take the medication about an hour before sexual activity and to complete the entire course of treatment.
Common side effects of Dapoxetine 30 mg Tablet include:
You should not use Dapoxetine 30 mg Tablet if you have taken a monoamine oxidase inhibitor (MAOI) before, or if you are taking a MAOI within the last 14 days.
Inform your doctor if you have taken any other medicines, including herbal products. Your doctor will determine whether your medication is safe for you to use.
This medication can cause drowsiness, dizziness, or fainting when you stand up quickly from lying down. If this occurs, do not drive or operate machinery. If you find you feel lightheaded, faint, suffer a heart attack or stroke, or experience any of these symptoms, stop using this medicine immediately.
Do not use Dapoxetine 30 mg Tablet if you have had a stroke or heart attack within the last 6 months. This medicine is not expected to cause a problem if you use Dapoxetine 30 mg Tablet for the treatment of erectile dysfunction.
The use of Dapoxetine 30 mg Tablet is not recommended if you have a history of seizures, epilepsy, or have had blood clots in the brain or lungs. Do not use Dapoxetine 30 mg Tablet if you have had a stroke or blood clot within the last 6 months.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
UnitSoldOther countriesThis product is a Prescription Only Medicine (S4) reviewed by our healthcare professionals. If you are not sure if you are using this or similar medications, please skip to provided information and find the source.
Healthylife reserves the right not to use this product by either you or a medical professional. You should not use this product with any other S4. If you have any questions about using this product, please consult your pharmacy.
Product information:
Healthylife is a a generic medication that contains the same active ingredient as brand-name Viagra. This is safe and effective treatment for erectile dysfunction. Erectile dysfunction is the inability to keep a hard and erect penis suitable for sexual activity. It may be necessary to limit the number of impotent men that may be prescribed this medication. This medication is intended for use by men who have impotence and not by women. It may diminish sexual desire a man experiencing difficulties in maintaining an erection. eNuva® tablets are taken by mouth, approximately 30 - 60 minutes before sexual activity. The onset of action of eNuva® tablets may vary depending on the individual and the dose taken. This medication is recommended when using sexual stimulation devices such as a Fortune 3D-Film Mounting System. eNuva® may also be taken on an empty stomach (into a glass of water) once daily.Healthylife contains the same active ingredient as Viagra, Sildenafil, and flibanserin. This is a prescription only medication, and care must be taken to avoid unexpected side effects or drug interactions. This medication is used to treat erectile dysfunction in men. It may lessen the severity and duration of symptoms associated with benign prostatic hyperplasia (BPH) or the risk of acute urinary retention (AUR). In BPH, the prostate gland (which contains the gland-stretching tissue that lineulates urine) is about 4 to 6 times bigger than eNuva® tablets. This is due to the effect of nitric oxide in the body. Lowering the prostate-specific pressure in the bladder, especially in men over the age of 65, can lead to a reduction in urine flow. If used with cyp. Inhibitors of CYP3A4, such as ritonavir or indinavir, may enhance the elimination of these drugs. Inhibitors of CYP3A4 may decrease the concentrations of these drugs. Nebivac® is used to treat certain types of HIV infection. It can also be used to treat a certain type of fungal infection in certain people. If you are taking any other medications, always consult the manufacturer's information regarding any other medications or supplements you are taking. Healthylife contains active ingredient Sildenafil, which is the same active ingredient as Viagra, sildenafil, and flibanserin.
ProductHealthylife contains the active ingredient Sildenafil, which is the same active ingredient as Viagra, sildenafil, and flibanserin. This is a prescription only medication and you should not take this medication with any other S4.
ShareSASA-10 Tablets (Sildenafil 100mg) - Share StatA series of clinical trials, funded by the NHS, are ongoing to evaluate the safety, tolerability, and pharmacokinetics of sildenafil citrate and its active metabolites in patients with erectile dysfunction (ED).
The primary objective of the current study was to evaluate the safety, tolerability, and pharmacokinetics of sildenafil citrate in a double-blind, placebo-controlled, and active-controlled phase 2 trial. A total of 521 patients were included. The primary end point was the change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study.
The primary end point was the change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study.
The secondary end points included changes from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study.
In the primary end point, the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was the change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study. The mean change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 3.7 (range, 1.0 to 6.4).
The changes from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study were 3.4 (range, 1.0 to 7.3) in the primary and secondary end points, and 3.4 (range, 1.0 to 7.4) in the treatment-related end points.
The mean change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 2.4 (range, 0.8 to 4.9) in the primary and secondary end points, and 2.3 (range, 0.8 to 5.0) in the treatment-related end points.
The mean change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 2.5 (range, 0.7 to 5.2) in the primary and secondary end points, and 2.6 (range, 0.6 to 4.0) in the treatment-related end points.
The mean change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 2.4 (range, 0.9 to 5.0) in the primary and secondary end points, and 2.3 (range, 0.9 to 5.0) in the treatment-related end points.
The change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 3.0 (range, 1.1 to 7.1) in the primary and secondary end points, and 3.4 (range, 1.0 to 7.4) in the treatment-related end points.
The mean change from baseline in the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the sum of the study was 2.1 (range, 0.9 to 5.3) in the primary and secondary end points, and 2.2 (range, 0.8 to 4.6) in the treatment-related end points.